Kathleen P. Bloch - Sep 18, 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role: Chief Financial Officer
Signature: /s/ Kathleen P. Bloch
Stock symbol: CTSO
Transactions as of: Sep 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/20/2023, 04:34 PM
Previous filing: Jul 11, 2023
Next filing: Dec 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTSO	Common Stock	Award	$0	+45K	+11.33%	$0.00	442K	Sep 18, 2023	Direct	F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTSO	Stock Option (Right to Buy)	Award	$0	+30K		$0.00	30K	Sep 18, 2023	Common Stock	30K	$1.98	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") which shall vest as follows: (i) 25,000 RSUs shall vest on the date of grant, (ii) 10,000 RSUs shall vest on the first anniversary of the date of grant, and (iii) 10,000 RSUs shall vest on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock, par value $0.001 per share (the "Common Stock") of CytoSorbents Corporation (the "Company") upon vesting.
F2	Includes: (i) the following RSUs that will be settled into Common Stock upon a "Change In Control" of the Company, as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 8,800 RSUs granted on March 15, 2018, (b) 15,700 RSUs granted on February 24, 2017, (c) 47,000 RSUs granted on June 7, 2016 and (d) 110,000 RSUs granted on April 8, 2015;
F3	(continued from footnote 2) (ii) the following RSUs (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the Reporting Person's continued service as of the applicable vesting date), and will be settled into common stock of the Company upon vesting: 18,500 RSUs granted on August 10, 2022; and
F4	(continued from footnote 3) (iii) 197,347 shares of Common Stock owned by the Reporting Person.
F5	These stock options were granted pursuant to the Plan. The shares underlying these stock options shall vest as follows: (i) 10,000 shares underlying these stock options shall vest on the date of grant, (ii) 10,000 shares underlying these stock options shall vest on the first anniversary of the date of grant, and (iii) 10,000 underlying these stock options shall vest on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.